[go: up one dir, main page]

NO20030127D0 - Indolderivater nyttige for behandling av CNS-forstyrrelser - Google Patents

Indolderivater nyttige for behandling av CNS-forstyrrelser

Info

Publication number
NO20030127D0
NO20030127D0 NO20030127A NO20030127A NO20030127D0 NO 20030127 D0 NO20030127 D0 NO 20030127D0 NO 20030127 A NO20030127 A NO 20030127A NO 20030127 A NO20030127 A NO 20030127A NO 20030127 D0 NO20030127 D0 NO 20030127D0
Authority
NO
Norway
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
useful
Prior art date
Application number
NO20030127A
Other languages
English (en)
Other versions
NO20030127L (no
NO323799B1 (no
Inventor
Jakob Felding
Benny Bang-Andersen
Garrick Paul Smith
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20030127D0 publication Critical patent/NO20030127D0/no
Publication of NO20030127L publication Critical patent/NO20030127L/no
Publication of NO323799B1 publication Critical patent/NO323799B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO20030127A 2000-07-21 2003-01-10 Indolderivater, farmasoytisk sammensetning inneholdende dem og deres anvendelse. NO323799B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001123 2000-07-21
PCT/DK2001/000507 WO2002008223A1 (en) 2000-07-21 2001-07-17 Indole derivatives useful for the treatment of cns disorders

Publications (3)

Publication Number Publication Date
NO20030127D0 true NO20030127D0 (no) 2003-01-10
NO20030127L NO20030127L (no) 2003-01-10
NO323799B1 NO323799B1 (no) 2007-07-09

Family

ID=8159625

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030127A NO323799B1 (no) 2000-07-21 2003-01-10 Indolderivater, farmasoytisk sammensetning inneholdende dem og deres anvendelse.

Country Status (29)

Country Link
US (1) US6743809B2 (no)
EP (1) EP1305307B1 (no)
JP (1) JP2004504396A (no)
KR (1) KR100851793B1 (no)
CN (1) CN1264838C (no)
AR (1) AR029858A1 (no)
AT (1) ATE266024T1 (no)
AU (2) AU8173801A (no)
BG (1) BG107528A (no)
BR (1) BR0112998A (no)
CA (1) CA2416212C (no)
CZ (1) CZ301114B6 (no)
DE (1) DE60103162T2 (no)
EA (1) EA004749B1 (no)
ES (1) ES2219554T3 (no)
HK (1) HK1059782A1 (no)
HR (1) HRP20030015A2 (no)
HU (1) HUP0302820A3 (no)
IL (2) IL153605A0 (no)
IS (1) IS2172B (no)
MX (1) MXPA02012927A (no)
NO (1) NO323799B1 (no)
NZ (1) NZ523436A (no)
PT (1) PT1305307E (no)
SK (1) SK286701B6 (no)
TR (1) TR200401488T4 (no)
UA (1) UA73995C2 (no)
WO (1) WO2002008223A1 (no)
ZA (1) ZA200300287B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4825679B2 (ja) 2003-11-17 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ピペリジン置換インドール又はこれらのヘテロ誘導体
TWI391387B (zh) * 2004-05-12 2013-04-01 Eisai R&D Man Co Ltd 具有哌啶環之吲哚衍生物
CA2606550C (en) 2005-04-30 2014-05-27 Boehringer Ingelheim International Gmbh Piperidine-substituted indoles
ATE537166T1 (de) 2006-10-27 2011-12-15 Boehringer Ingelheim Int Piperidylpropanthiole als ccr3-modulatoren
CN101486654B (zh) * 2009-03-04 2012-10-10 西安近代化学研究所 2-甲基-3-硝基苯乙酸合成方法
CN110041318B (zh) * 2018-01-17 2022-07-29 中国科学院上海药物研究所 一类多巴胺d5受体激动剂及其制备和应用
CN110498789B (zh) * 2018-05-17 2022-04-05 上海医药工业研究院 芳烷哌啶类衍生物及其在多靶点抗抑郁症中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322470A1 (de) * 1973-05-04 1974-11-21 Boehringer Sohn Ingelheim Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
AT332401B (de) * 1973-11-26 1976-09-27 Roussel Uclaf Verfahren zur herstellung von neuen (4'-(3''-indolyl)-piperidino)-alkylarylketonderivaten
GB2208646B (en) * 1987-08-13 1991-06-26 Glaxo Group Ltd Indole derivatives
GB8719167D0 (en) 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
EP0664801A1 (en) * 1992-08-05 1995-08-02 JOHN WYETH & BROTHER LIMITED Amide derivatives
DE69400824T2 (de) * 1993-04-22 1997-03-13 Pfizer Research And Development Co., N.V./S.A., Dublin Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
ES2063700B1 (es) * 1993-04-28 1995-07-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents

Also Published As

Publication number Publication date
HUP0302820A3 (en) 2006-04-28
HRP20030015A2 (en) 2005-02-28
IL153605A0 (en) 2003-07-06
AR029858A1 (es) 2003-07-16
ZA200300287B (en) 2004-03-02
EP1305307A1 (en) 2003-05-02
SK286701B6 (sk) 2009-03-05
EA200300179A1 (ru) 2003-06-26
TR200401488T4 (tr) 2004-08-23
EP1305307B1 (en) 2004-05-06
CZ2003196A3 (cs) 2003-05-14
KR20030017643A (ko) 2003-03-03
CA2416212A1 (en) 2002-01-31
NO20030127L (no) 2003-01-10
JP2004504396A (ja) 2004-02-12
UA73995C2 (en) 2005-10-17
CN1264838C (zh) 2006-07-19
KR100851793B1 (ko) 2008-08-13
PT1305307E (pt) 2004-09-30
US6743809B2 (en) 2004-06-01
WO2002008223A1 (en) 2002-01-31
DE60103162D1 (de) 2004-06-09
AU2001281738B2 (en) 2006-12-21
IS6663A (is) 2002-12-23
HUP0302820A2 (hu) 2003-12-29
ATE266024T1 (de) 2004-05-15
IS2172B (is) 2006-11-15
CA2416212C (en) 2007-10-30
CN1451002A (zh) 2003-10-22
MXPA02012927A (es) 2003-05-15
US20030166664A1 (en) 2003-09-04
NO323799B1 (no) 2007-07-09
ES2219554T3 (es) 2004-12-01
CZ301114B6 (cs) 2009-11-11
SK2032003A3 (en) 2003-06-03
AU8173801A (en) 2002-02-05
EA004749B1 (ru) 2004-08-26
NZ523436A (en) 2004-07-30
DE60103162T2 (de) 2005-05-04
BG107528A (bg) 2003-10-31
PL359157A1 (en) 2004-08-23
IL153605A (en) 2008-07-08
HK1059782A1 (en) 2004-07-16
BR0112998A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20014047D0 (no) Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO20026005L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
HRP20030052A2 (en) 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20026029L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20026028L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
HK1059086A1 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
NO20011189L (no) Innretning for behandling av suspensjoner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees